CHF-1024
From Wikipedia, the free encyclopedia
Jump to navigation
Jump to search
Pharmaceutical compoundTemplate:SHORTDESC:Pharmaceutical compound
| Clinical data | |
|---|---|
| Other names | CHF1024; 5,6-Dihydroxy-2-methylaminotetralin |
| Drug class | Dopamine D2 recpetor agonist; α2-Adrenergic receptor agonist |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C11H15NO2 |
| Molar mass | 193.246 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
CHF-1024, also known as 5,6-dihydroxy-2-methylaminotetralin, is a dopamine D2 receptor agonist and α2-adrenergic receptor agonist of the 2-aminotetralin family.[1][2] It is a cyclized phenethylamine analogue of the neurotransmitter dopamine.[1] The drug is the active form of nolomirole (CHF-1035), a prodrug of CHF-1024 and the N,N-diisobutyryl diester of the compound.[1][2] Nolomirole was investigated for the treatment of heart failure but was never marketed.[1][2]
See also
[edit | edit source]References
[edit | edit source]
| α1 |
| ||||
|---|---|---|---|---|---|
| α2 |
| ||||
| β |
| ||||
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) | |||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
Retrieved from "http://70.231.62.181/index.php?title=CHF-1024&oldid=23323846"
Hidden categories: